Bacterial Pneumonia and Acute Kidney Injury: Association and Impact on Outcomes of Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States.

Q3 Medicine
Open Respiratory Medicine Journal Pub Date : 2026-02-18 eCollection Date: 2026-01-01 DOI:10.2174/0118743064443250260210065237
Thai Truong, Carlos Pichardo, Chanmi Park, Erick Phocco, Pedro Arias-Sanchez, Jeremy Kuszel, Lisa Glass
{"title":"Bacterial Pneumonia and Acute Kidney Injury: Association and Impact on Outcomes of Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States.","authors":"Thai Truong, Carlos Pichardo, Chanmi Park, Erick Phocco, Pedro Arias-Sanchez, Jeremy Kuszel, Lisa Glass","doi":"10.2174/0118743064443250260210065237","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aims to investigate the association between bacterial pneumonia and acute kidney injury (AKI), which develops during hospitalizations for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and their impact on patient outcomes.</p><p><strong>Methods: </strong>We performed a retrospective observational study on the United States National Inpatient Sample (USNIS) from 2016 to 2022, using ICD-10 codes to identify patients admitted to hospitals with an AECOPD who developed bacterial pneumonia and/or AKI during their hospital stay. We compared the clinical outcomes, including endotracheal intubation, in-hospital length of stay, and all-cause hospital mortality among four groups of patients: AECOPD, AECOPD with bacterial pneumonia and no AKI (PAECOPD), AECOPD with AKI and no bacterial pneumonia (KAECOPD), AECOPD with both bacterial pneumonia and AKI (PKAECOPD). We investigated the microorganism distribution of bacterial pneumonia and mortality by pathogen. We also used multivariate logistic and linear regression to investigate the correlation between outcomes and variables, including age, gender, race, hospital bed size, hospital location, bacterial pneumonia, AKI, and Charlson's comorbidity index.</p><p><strong>Results: </strong>There were 2,548,188 weighted admissions, including 2,247,833 cases of AECOPD (88.21%); 34,930 cases of PAECOPD (1.37%); 258,360 cases of KAECOPD (10.14%); and 7,065 cases of PKAECOPD (0.28%). The average age of patients who died in hospitals was 6 years older than that of survivors (73.19 <i>vs</i> 67.70 years, <i>p</i><0.01). Patients requiring endotracheal intubation were, on average, a year younger than those who did not (66.61 <i>vs</i> 67.77 years, <i>p</i><0.01). White patients had poorer survival than Black, Hispanic, and other races. Females had lower hospital mortality than males by odds ratio (OR) 0.91 (<i>p</i>=0.004). AECOPD patients with bacterial pneumonia had a higher AKI rate than those without bacterial pneumonia (16.82% <i>vs</i> 10.31%, <i>p</i><0.01). The PKAECOPD group had the poorest outcomes compared with the other groups, including higher endotracheal intubation incidence (27.18%), longer hospital stay (12.89 days), and higher all-cause hospital mortality (13.39%). Factors leading to increased all-cause hospital mortality included endotracheal intubation (OR 32.75, <i>p</i><0.01), AKI (OR 2.33, <i>p</i><0.01), bacterial pneumonia (OR 1.71, <i>p</i><0.01), Charlson's comorbidity index (OR 1.10, <i>p</i><0.01), and older age (OR 1.05, <i>p</i><0.01). Factors leading to increased hospital stay by at least a day included endotracheal intubation (6.13 days, <i>p</i><0.01), bacterial pneumonia (3.03 days, <i>p</i><0.01), and AKI (1.12 days, <i>p</i><0.01). The most commonly identified pathogens causing bacterial pneumonia included other gram-negative bacilli (12.47%), <i>Pseudomonas aeruginosa</i> (11.54%), <i>Streptococcus pneumoniae</i> (7.22%), Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) (7.00%), <i>Mycoplasma pneumoniae</i> (4.70%), and <i>Hemophilus influenzae</i> (4.63%). In approximately forty percent of cases, no specific pathogen was identified. Mortality was highest for patients with \"other bacteria\" (23.43%), MRSA (22.86%), and <i>Pseudomonas aeruginosa</i> (20%).</p><p><strong>Discussion: </strong>Patients admitted with an AECOPD had a high incidence of AKI during hospital admission, approximately 10%. Patients with an AECOPD who developed bacterial pneumonia represented a small proportion of admissions (1.65%) but had a higher risk of AKI (16.82%). These patients were likely to be infected with pathogens including <i>Pseudomonas aeruginosa</i>, other gram-negative bacteria, and MRSA. Patients with both AKI and bacterial pneumonia had the highest all-cause hospital mortality.</p><p><strong>Conclusion: </strong>Our study found that hospitalized AECOPD patients with bacterial pneumonia had a higher rate of AKI than those without bacterial pneumonia, and the population of AECOPD patients with both bacterial pneumonia and AKI had markedly higher all-cause hospital mortality, longer hospital stays, and greater need for endotracheal intubation. Therefore, minimizing the association between bacterial pneumonia and AKI may help improve the prognosis of patients admitted with an AECOPD.</p>","PeriodicalId":39127,"journal":{"name":"Open Respiratory Medicine Journal","volume":"20 ","pages":"e18743064443250"},"PeriodicalIF":0.0000,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13071513/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Respiratory Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0118743064443250260210065237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: This study aims to investigate the association between bacterial pneumonia and acute kidney injury (AKI), which develops during hospitalizations for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), and their impact on patient outcomes.

Methods: We performed a retrospective observational study on the United States National Inpatient Sample (USNIS) from 2016 to 2022, using ICD-10 codes to identify patients admitted to hospitals with an AECOPD who developed bacterial pneumonia and/or AKI during their hospital stay. We compared the clinical outcomes, including endotracheal intubation, in-hospital length of stay, and all-cause hospital mortality among four groups of patients: AECOPD, AECOPD with bacterial pneumonia and no AKI (PAECOPD), AECOPD with AKI and no bacterial pneumonia (KAECOPD), AECOPD with both bacterial pneumonia and AKI (PKAECOPD). We investigated the microorganism distribution of bacterial pneumonia and mortality by pathogen. We also used multivariate logistic and linear regression to investigate the correlation between outcomes and variables, including age, gender, race, hospital bed size, hospital location, bacterial pneumonia, AKI, and Charlson's comorbidity index.

Results: There were 2,548,188 weighted admissions, including 2,247,833 cases of AECOPD (88.21%); 34,930 cases of PAECOPD (1.37%); 258,360 cases of KAECOPD (10.14%); and 7,065 cases of PKAECOPD (0.28%). The average age of patients who died in hospitals was 6 years older than that of survivors (73.19 vs 67.70 years, p<0.01). Patients requiring endotracheal intubation were, on average, a year younger than those who did not (66.61 vs 67.77 years, p<0.01). White patients had poorer survival than Black, Hispanic, and other races. Females had lower hospital mortality than males by odds ratio (OR) 0.91 (p=0.004). AECOPD patients with bacterial pneumonia had a higher AKI rate than those without bacterial pneumonia (16.82% vs 10.31%, p<0.01). The PKAECOPD group had the poorest outcomes compared with the other groups, including higher endotracheal intubation incidence (27.18%), longer hospital stay (12.89 days), and higher all-cause hospital mortality (13.39%). Factors leading to increased all-cause hospital mortality included endotracheal intubation (OR 32.75, p<0.01), AKI (OR 2.33, p<0.01), bacterial pneumonia (OR 1.71, p<0.01), Charlson's comorbidity index (OR 1.10, p<0.01), and older age (OR 1.05, p<0.01). Factors leading to increased hospital stay by at least a day included endotracheal intubation (6.13 days, p<0.01), bacterial pneumonia (3.03 days, p<0.01), and AKI (1.12 days, p<0.01). The most commonly identified pathogens causing bacterial pneumonia included other gram-negative bacilli (12.47%), Pseudomonas aeruginosa (11.54%), Streptococcus pneumoniae (7.22%), Methicillin-resistant Staphylococcus aureus (MRSA) (7.00%), Mycoplasma pneumoniae (4.70%), and Hemophilus influenzae (4.63%). In approximately forty percent of cases, no specific pathogen was identified. Mortality was highest for patients with "other bacteria" (23.43%), MRSA (22.86%), and Pseudomonas aeruginosa (20%).

Discussion: Patients admitted with an AECOPD had a high incidence of AKI during hospital admission, approximately 10%. Patients with an AECOPD who developed bacterial pneumonia represented a small proportion of admissions (1.65%) but had a higher risk of AKI (16.82%). These patients were likely to be infected with pathogens including Pseudomonas aeruginosa, other gram-negative bacteria, and MRSA. Patients with both AKI and bacterial pneumonia had the highest all-cause hospital mortality.

Conclusion: Our study found that hospitalized AECOPD patients with bacterial pneumonia had a higher rate of AKI than those without bacterial pneumonia, and the population of AECOPD patients with both bacterial pneumonia and AKI had markedly higher all-cause hospital mortality, longer hospital stays, and greater need for endotracheal intubation. Therefore, minimizing the association between bacterial pneumonia and AKI may help improve the prognosis of patients admitted with an AECOPD.

细菌性肺炎和急性肾损伤:美国慢性阻塞性肺疾病(COPD)急性加重住院患者预后的关联和影响
本研究旨在探讨细菌性肺炎与慢性阻塞性肺疾病(AECOPD)急性加重住院期间发生的急性肾损伤(AKI)之间的关系及其对患者预后的影响。方法:我们对2016年至2022年美国国家住院患者样本(USNIS)进行了一项回顾性观察研究,使用ICD-10代码识别住院期间发生细菌性肺炎和/或AKI的AECOPD患者。我们比较了四组患者的临床结果,包括气管插管、住院时间和全因住院死亡率:AECOPD、AECOPD合并细菌性肺炎且无AKI (PAECOPD)、AECOPD合并AKI且无细菌性肺炎(KAECOPD)、AECOPD合并细菌性肺炎和AKI (PKAECOPD)。对细菌性肺炎的微生物分布及病原菌致死率进行了调查。我们还使用多变量逻辑和线性回归来调查结果与变量之间的相关性,包括年龄、性别、种族、医院床位大小、医院位置、细菌性肺炎、AKI和Charlson合并症指数。结果:加权入院2548188例,其中AECOPD 2247833例(88.21%);PAECOPD 34930例(1.37%);KAECOPD 258360例(10.14%);PKAECOPD 7065例(0.28%)。住院死亡患者的平均年龄比存活患者大6岁(73.19岁vs 67.70岁,vs 67.77岁,pp=0.004)。AECOPD合并细菌性肺炎患者AKI发生率高于未合并细菌性肺炎患者(16.82% vs 10.31%)、pppppppppp假单胞菌(11.54%)、肺炎链球菌(7.22%)、耐甲氧西林金黄色葡萄球菌(MRSA)(7.00%)、肺炎支原体(4.70%)、流感嗜血杆菌(4.63%)。在大约40%的病例中,没有发现特定的病原体。死亡率最高的是“其他细菌”(23.43%)、MRSA(22.86%)和铜绿假单胞菌(20%)。讨论:AECOPD患者在住院期间AKI的发生率很高,约为10%。发生细菌性肺炎的AECOPD患者占入院患者的一小部分(1.65%),但AKI的风险较高(16.82%)。这些患者可能感染了包括铜绿假单胞菌、其他革兰氏阴性菌和MRSA在内的病原体。AKI和细菌性肺炎患者的全因死亡率最高。结论:我们的研究发现,住院的AECOPD合并细菌性肺炎患者的AKI发生率高于非细菌性肺炎患者,合并细菌性肺炎和AKI的AECOPD患者的全因死亡率明显更高,住院时间更长,气管插管需求更大。因此,尽量减少细菌性肺炎和AKI之间的关联可能有助于改善AECOPD患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Open Respiratory Medicine Journal
Open Respiratory Medicine Journal Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.70
自引率
0.00%
发文量
17
期刊介绍: The Open Respiratory Medicine Journal is an Open Access online journal, which publishes research articles, reviews/mini-reviews, letters and guest edited single topic issues in all important areas of experimental and clinical research in respiratory medicine. Topics covered include: -COPD- Occupational disorders, and the role of allergens and pollutants- Asthma- Allergy- Non-invasive ventilation- Therapeutic intervention- Lung cancer- Lung infections respiratory diseases- Therapeutic interventions- Adult and paediatric medicine- Cell biology. The Open Respiratory Medicine Journal, a peer reviewed journal, is an important and reliable source of current information on important recent developments in the field. The emphasis will be on publishing quality articles rapidly and making them freely available worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书